id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S10366 R38043 |
Zhu - Azoles (Local routes), 2020 | Cleft lip | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Route of exposure Azoles: Local (NOS) | 0.97 [0.67;1.41] C | 29/82,090 683/1,875,257 | 712 | 82,090 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4170 R9635 |
Rotem - Clotrimazole (Vaginal), 2018 | Cleft lip/palate | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Route of exposure Azoles: Vaginal | 0.76 [0.19;3.09] C | 2/1,993 126/95,781 | 128 | 1,993 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17545 R73867 |
Carter - Clotrimazole, 2008 | Cleft lip with or without cleft palate | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No Route of exposure Azoles: Local (NOS) | 0.29 [0.02;5.13] C | 0/7 1,086/5,853 | 1,086 | 7 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17524 R73719 |
Czeizel - Clotrimazole, 1999 | Cleft lip with or without palate | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes Matched Route of exposure Azoles: Local (NOS) | 0.93 [0.48;1.80] | 18/516 1,056/33,362 | 1,074 | 516 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 4 studies | 0.94 [0.68;1.28] | 3,000 | 84,606 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Local routes; 2: Vaginal;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded